Correspondence Are ORS brands in India using the name of WHO judiciously? Are ORS brands in India using the name of WHO judiciously? Are ORS brands in India using the name of WHO judiciously? Are ORS brands in India using the name of WHO judiciously? Are ORS brands in India using the name of WHO judiciously?
Diarrhea is the passage of loose, liquid or watery stools.
Table 1
In diarrhea, the change in consistency and character of stools are more important than the frequency of stools.
[1] The World
The new and old formula oral rehydration salts, its constituents and electrolytes
Health Organisation (WHO) and UNICEF define acute diarrhea as an attack of a sudden nature that usually lasts 3-7 days, diarrhea.
[1] Thus diarrhea continues to be a major health
concern in developing countries, including India.
Introduction of oral rehydration by WHO in 1969 simplified the treatment of diarrheal diseases.
[2] Oral rehydration salts (ORS) were reported to treat 90-95% of acute diarrheal new formula was expected to have lowered price by 15% due diseases.
[1] The composition of ORS recommended by WHO, [2] to decreased quantity of ingredients. in 1969 was as follows:
The course on rational use of medicines in community" collected by 2.9 g trisodium citrate dehydrate.
[2] It was suggested that data for those formulations in the market which contained the the composition of ORS should be changed according to the WHO name and/or the WHO/UNICEF ORS logo. Their findings loss of electrolytes.
are presented in Table 2 . Except for adult cholera, in other conditions, like cholera Most of the branded ORS formulations with WHO name/ in children, enterotoxigenic E. coli and rotavirus infection, the logo have added flavors of orange or lemon, which WHO Na + loss is less than 90 mMol/l.
[2] Hence, if these conditions considers as unnecessary. The logo "WHO recommended are treated with the older ORS formula, there is a chance of formula" is not clearly readable in most brands. Some have development of hypernatremia with replacement of 4-5 l of printed it as "WHO formula". One company has mentioned it body fluids. Therefore in 2002, WHO and UNICEF recommended as "new formula" whereas the contents are of the old one.
Old formula
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an improved ORS formula with lesser Na + and glucose, as a result of which the total osmolality is far less than the previous formula.
[2]
The comparison of the old and new formula is shown in Table 1 .
The advantages of 2002 formula have been quoted as: -lower osmolality allows quicker absorption of fluids, -less chances of hypernatremia, -more stability of reconstituted solution, -decreased number of hospitalizations, -less cost of manufacturing.
The WHO and UNICEF recommend nations produce of the new ORS [2] with WHO providing the updated international quality specifications for the new formula and UNICEF the leading supplier of ORS to economically poor countries. The Some companies are manufacturing smaller pouches to be dissolved in 200 ml of water, which may not be correctly diluted thereby affecting the final osmolality. The font size of WHO on one brand is so large that it looks like brand promotion with the name of WHO. While the company supplying the ORS to the government has carried the name of WHO in small font size, it is worth probing why others do not follow the same practice.
Due to the confusion in ORS concentrations available in the market, even the literate feel confused in identifying the one recommended by WHO, the composition that is correct and the latest, and also as to whether WHO recommends the orange / lemon flavors of ORS that are available in the market. The prescribers routinely advice the patients to dissolve the whole ORS pouch in 1litre water and if the patient buys a smaller pouch, the end result can well be imagined. Paragraph 28 of WHO Criteria for Medicinal Drug Promotion, which concerns packaging and labeling reads that "Appropriate information being important to ensure the rational use of drugs, all packaging and labeling material should provide information consistent with that approved by the country's drug regulator y authority. Where one does not exist or is rudimentary, such material should provide information consistent with that approved by the drug regulatory authority of the country from which the drug is imported or other reliable sources of information with similar content. Any wording and illustration on the package and label should conform to the Correspondence but if the watchdogs are barking, the master needs to have a look at what the noise is all about.
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This brings up questions as to whether all that which is being Jabalpur, India: Banarasidas Bhanot Publishers; 2005. practiced by ORS brands in India is ethical.
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The lack of importance given to medicine promotion in 
